Tag - Face

Physicians Formula Holdings Inc. (Nasdaq:FACE) soared by 11.6% after the company’s board approved a plan to buy back up to $10 million worth of its outstanding common stock.

The Azusa, Calif.-based cosmetic company made the announcement after the bell Thursday.

The stock is at $6.63, up $0.69 from Thursday’s close. Shares have ranged between $5.45 and $13.49 in the past year.

For detailed price information and news stories on Physicians Formula, click FACE.

<strong>Duckwall Alco Stores Inc. </strong>(Nasdaq:<a href="/ticker/duck">DUCK</a>), <strong>Gladstone Commercial 7.75% Pref Shs Series A </strong>(Nasdaq:<a href="/ticker/goodp">GOODP</a>) and <strong>Power Medical Interventions Inc.</strong> (Nasdaq:<a href="/ticker/pmii">PMII</a>) are among the biggest percentage gainers in Friday's trading among companies with market capitalizations under $1 billion.<br /> <br /> Also included among the results: <strong>Aventine Renewable Energy Holdings Inc. </strong>(Nasdaq:AVR), <strong>Apco Argentina Inc. </strong>(Nasdaq:<a href="/ticker/apagf">APAGF</a>), <strong>Micromet Inc. </strong>(Nasdaq:<a href="/ticker/miti">MITI</a>), <strong>Physicians Formula Holdings Inc. (</strong>Nasdaq:<a href="/ticker/face">FACE</a>),<strong> FortuNet Inc. </strong>(Nasdaq:<a href="/ticker/fnet">FNET</a>) and <strong>Delek US Hldg Inc. </strong>(Nasdaq:<a href="/ticker/dk">DK</a>).<br /> <br /> Here are the biggest percentage gainers among small caps:

Seabridge Gold Inc. (Nasdaq:SA), Reddy Ice Holdings Inc. (Nasdaq:FRZ) and MAG Silver Corp. (Nasdaq:MVG) are among the new 52-week lows in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Affirmative Insurance Holdings Inc. (Nasdaq:AFFM), Macquarie Infrastructure Co. LLC (Nasdaq:MIC), Chindex International Inc. (Nasdaq:CHDX), Physicians Formula Holdings Inc. (Nasdaq:FACE), Trico Marine Services Inc. (Nasdaq:TRMA) and North Central Bancshares Inc. (Nasdaq:FFFD).

Here are the new 52-week lows among small caps:

Avanex Corp. (Nasdaq:AVNXD), Physicians Formula Holdings Inc. (Nasdaq:FACE) and Koss Corp. (Nasdaq:KOSS) are among the new 52-week lows in Wednesday's trading among companies with market capitalizations under $1 billion.

Here are the new 52-week lows among small caps:

Pacific Sunwear of California Inc. (Nasdaq:PSUN) Physicians Formula Holdings Inc (Nasdaq:FACE) and ExlService Holdings Inc. (Nasdaq:EXLS) are among the new 52-week lows in Friday's trading among companies with market capitalizations under $1 billion.           
        
Here are the new 52-week lows among small caps: 

Royal Bank Pennsylvania (Nasdaq:RBPAA), CryptoLogic Ltd. (Nasdaq:CRYP) and Reddy Ice Holdings Inc. (Nasdaq:FRZ) are among the new 52-week lows in Thursday's trading among companies with market capitalizations under $1 billion.   

Also included among the results: China East Air (Nasdaq:CEA), Bancorp Bank (Nasdaq:TBBK), Physicians Formula Holdings Inc. (Nasdaq:FACE), Radiant Systems Inc. (Nasdaq:RADS), HMN Financial Inc. (Nasdaq:HMNF) and ExlService Holdings Inc. (Nasdaq:EXLS).        

Here are the new 52-week lows among small caps: 

Comverge Inc (Nasdaq:COMV), China East Air Depository Receipt (Nasdaq:CEA) and China Southern Airlines ADR Each representing 50 H Ord Shs (Nasdaq:ZNH) are among the new 52-week lows in Tuesday's trading among companies with market capitalizations under $1 billion.           

Also included among the results: Horsehead Holding Corp (Nasdaq:ZINC), CryptoLogic Ltd (Nasdaq:CRYP), Physicians Formula Holdings Inc (Nasdaq:FACE), Jeffersonville Bancorp (Nasdaq:JFBC), Strattec Security Corp (Nasdaq:STRT) and Greater China Fund Inc (Nasdaq:GCH).  

Here are the new 52-week lows among small caps:     

Small-cap stocks edged lower shortly after the opening, pulled down by weakness in the financial arena, a bounce in crude oil prices and long profit-taking following two sessions of huge gains. At 10:00 a.m. ET, the Russell 2000 (NYSE:IWM) was down 4.22, or 0.56%, at 746.84. The Dow was off 0.58%, while the S&P 500 was down 0.51%.

Financial stocks were back in the spotlight this morning, pulled down by a batch of fresh bearish news overnight and a spate of analyst downgrades in various big names. Morgan Stanley (NYSE:MS) and Wachovia Corp. (NYSE:WB) were pressured by the auction-rate security fiasco, as WB settled a probe on the issue and lowered Q2 numbers, while MS offered to reimburse investors. It’s a painful hit to the bottom line that the number one bank Citigroup Inc. (NYSE:C) already has faced. In addition, Oppenheimer analysts lowered the outlook for Goldman Sachs Group Inc. (NYSE:GS). Shortly after the open, MS was down 3.0%, WB off 4.5%, C down 1.2% and GS down 3.3%. The Financial Select SPDR was down 1.9%.

The market also frowned upon a sudden recovery bounce in crude oil prices, which saw the market on black gold move from three-month lows near $113 overnight back toward the $115 zone into the stock market opening. The rise in crude was tied to news that some production and transport in the Georgia region was going to be offline, even though Russian officials have ordered an end to the military conflict.

Elsewhere on the commodity inflation front, corn futures were called lower following USDA’s August production report, which forecast a larger crop than expected. However, softs markets were climbing this morning and the iPath GSCI Total Return commodities index was up about 0.3% in early trading. After huge declines in recent days, a consolidation move or bounce in commodities certainly wouldn’t . . .

Shares of Physicians Formula Holdings, Inc. (Nasdaq: FACE) are climbing higher today after the cosmetics company reported better-than-expected third-quarter earnings after Monday’s close. 

For the three months ended Sept. 30, the Azusa, Calif.-based company recorded net income of $0.06 per share, 125% ahead of the Thomson Financial mean estimate of a net loss of $0.04 per share. For the third quarter of 2006 the small cap recorded EPS of $0.02 per share.

The current quarter’s strong bottom-line was propped up by the roll over of promotion expenses for the company’s artwork design on Organic Wear from the third quarter to the fourth quarter, as well as a favorable shift in product mix toward higher margin face products.

Net sales were $19.8 million, an increase of 9.4% from $18.1 million for the same period a year ago. Analysts were expecting sales of $19.38 million.

Physician’s Organic Wear line was well received by the company’s retailer partners; however, performance was partially offset by a continued soft consumer spending environment.

The company reiterated its outlook for its fourth-quarter revenue and raised its net sales outlook for full year, but lowered its expectations for its fourth-quarter net due to a rollover of marketing expenses from the third quarter to the fourth quarter.

Physician’s formula expects fourth quarter earnings between $0.25 and $0.31 per share, compared with $0.22 earned in the fourth quarter last year. Five analysts polled by Thomson are on average forecasting earnings of $0.31 per share.

Fourth quarter sales are expected to range from $31 million to $33 million, while four analysts are on average expecting sales of $32.3 million for the fourth quarter. The company earned $26.54 million in sales for the same quarter last year.

For the full year, the company expects earnings per share in the range of $0.52 to $0.58 per share on revenues in the range of $108 million to $111 million. Five analysts polled by Thomson are on average expecting earnings of $0.56 per share, while four analysts polled by Thomson are on average anticipating revenues of $109.53 million.

Shares of Physicians (FACE) gained 10.97%, or $1.26, to $12.75 at 1:00 p.m. ET. Formula Shares of Physicians Formula have been trading in the range of $8.26 to $23.25 for the past 52 weeks.

Shares of Physicians Formula Holdings Inc. (Nasdaq: FACE) closed higher today after Citigroup upgraded the cosmetics company to a “buy” rating from “hold” and increased its target price to $13 from $12.

Citigroup analyst Wendy Nicholson said she thinks the stock has bottomed out from a fundamental and valuation standpoint and “now offers an attractive entry point.”

Shares of Physicians Formula have declined 60% since April on account of negative earnings revisions, poor communication from management and an overall weaker consumer spending environment, according to Nicholoson. The company now trades at 13 times Nicholson’s revised calendar year 2008 EPS estimate.

Shares of Physicians Formula Holdings, Inc. (Nasdaq: FACE) plunged today after the cosmetics company reported it swung to a loss in the second quarter and downwardly revised its guidance for the remainder of the year.

For the three months ended June 30, the Azusa, Calif.-based company recorded a net loss of $0.04, while four analysts polled by Thomson Financial were anticipating a profit of $0.03 per share on average. Excluding a $0.02 per share charge for stock-based compensation and a $0.03 per share charge of one-time secondary equity offering costs, adjusted net income per diluted share would have been $0.01. Physician’s second quarter net loss compares with net income of $0.14 per share a year earlier.

Net sales declined 4.2% to $22.1 million, from $23.1 million in the same period a year ago. The Street was calling for revenues of $21.47 million.

Today Wachovia downgraded Physicians Formula to a rating of “market perform” from “market outperform,” while Piper Jaffray lowered its price target on the company to $15 from $22.

Piper Jaffray’s commented in a research note, “In what should have, in our view, amounted to an uneventful quarter--in-line second quarter results and a reiteration of guidance--we believe FACE shares will likely go lower on yet again, another earnings revision.”

Accredited Home Lenders Holding Co. (Nasdaq: LEND), Physicians Formula Holdings, Inc. (Nasdaq: FACE) and STEC, Inc. (Nasdaq: STEC) are among the most actively traded companies in Tuesday pre-market trading among those with market capitalizations under $500 million:

Physicians Formula Holdings, Inc. (Nasdaq: FACE) tumbled to a 52-week low Tuesday after the personal care products maker cut its guidance for the second quarter of 2007 and the full fiscal year. 

Shares fell 25.3%, or $4.02, to close at $11.88, before establishing a low for the year of $11.88.

For the second quarter ended June 30, 2007, Physicians Formula now expects to book net sales in the range of approximately $21 million to $22 million, a decrease of 5% to 9% from $23.1 million for the same period last year.  This compares with the previous net sales outlook of approximately $24.5 million to $25.5 million.

The California-based company expects to record a net loss per diluted common share for the second quarter in range of $0.07 to $0.04, compared with the previous outlook of a loss in the range of $0.04 to $0.01 per diluted common share. Three analysts polled by Thomson Financial expected $0.00 per share for the second quarter.

"Even though we achieved gross sales growth … for the first six months of 2007 and we continue to expand our market share in the masstige market, our updated outlook for net sales and earnings in the second quarter of 2007 is lower than we previously expected,” said Physicians Formula CEO Ingrid Jackel.

These are the biggest percentage losers in Tuesday's trading among companies with market capitalizations under $500 million:

Stocks are down following sour earnings reports from major players as cautious investors await a speech by U.S. Federal Reserve Chairman Ben Bernanke.

At 10:26 a.m. ET the Russell 2000 had lost 6.56 points, or 0.77 percent, to 846.68. The Dow Jones Industrial Average had shed 53.41 points, or 0.39 percent, to 13,596.56.

Fed Chairman Ben Bernanke will talk about inflation when he addresses the National Bureau of Economic Research this afternoon. Stocks will most likely fall and the chances of a cut in the federal funds rate will all but evaporate should the head of the U.S. central bank suggest that inflation remains a worry.

Elsewhere, Atlanta-based home improvement retailer Home Depot Inc. (NYSE: HD) announced this morning that its earnings for the year will fall more the previously forecast due to weakness in the U.S. housing sector.

Similarly, retailer Sears Holdings Corp. (Nasdaq: SHLD) reported this morning that same store sales for the nine-week period ended July 7 dropped 3.9% at its Kmart stores and 4% at its domestic Sears stores.

The following were the most actively traded companies in Tuesday’s trading among those with market capitalizations under $500 million:

Shares of Ocean Bio-Chem Inc. (Nasdaq: OBCI) are soaring on news this morning that the Fort Lauderdale, Fla.-based maker of a line of appearance and maintenance products for boats saw its sales for the second quarter of 2007 rise to $5.72 million from $4.33 million a year earlier. Analyst estimates were not available. The stock is up $0.92, or 53%, to $2.65.

Kensey Nash Corp. (Nasdaq: KNSY) has decided to reduce its costs by cutting all activities on its embolic protection platform, the Exton, Pa.-based provider of medical technology solutions announced this morning. Embolic protection devices serve to capture and/or remove debris created after coronary surgery. Shares are up $1.68, or 6%, to $29.00.

Physicians Formula Holdings, Inc. (Nasdaq: FACE) lowered its Q2 sales guidance to $21 million, from $22 million.

Ariad Pharmaceuticals, Inc. (Nasdaq: ARIA) reported a federal court ruled in its favor in a patent infringement case against Eli Lilly and Co. (NYSE: LLY).

Medical technology company Kensey Nash Corp. (Nasdaq: KNSY) reported it’s ceasing embolic protection activities. The closing of the operations will cost the company $5.1 million, or $0.28 per share, which will be recorded in the 2007 and 2008 fiscal years.

The following are the most actively traded companies in Tuesday pre-market trading among those with market capitalizations under $500 million:

The Russell 2000 index and the Dow are in positive territory following news that U.S. personal incomes and consumer spending both grew in May, albeit less than expected.

At 10:08 a.m. ET the Russell 2000 had added 5.84 points, or 0.70 percent, to 844.87. Dow Jones Industrial Average was up 90.96 points, or 0.68 percent, to 13,513.24.

Personal income rose at a rate of 0.5% in May, the U.S. Commerce Department said before the opening. Economists were looking for a rise of 0.6%. Personal income fell 0.2% in April.

Consumer spending added 0.5% in May, below the forecast rise of 0.7%.

Investors’ upbeat attitude is probably mostly due to news that the price index for personal consumption expenditures, a key inflation indicator, rose just 0.5% in May. The so-called “core” index, which excludes food and energy, added a miniscule 0.1% in May, and only 1.9% from a year earlier.

U.S. stocks have moved closer to the flat line this afternoon, recovering slightly from their morning losses. At 2:54 p.m. ET the Russell 2000 had lost 0.25 points, or 0.03%, to 846.03. The Dow Jones Industrial Average was down 3.57 points, or 0.03%, to 13,609.41.

Shares of Cardica Inc. (Nasdaq: CRDC) are in positive territory following news of a deal to develop and commercialize a device that corrects a common heart defect. The Redwood City, Calif.-based manufacturer of systems for coronary artery bypass surgery will partner with medical devices maker Cook Group Inc. and get $0.9 million in upfront fees, the company said before the start of trading.

AeroCentury Corp. (AMEX: ACY) shares are down after two of the company’s directors reported in SEC filings today and Wednesday that they disposed of 770 shares.

Arrowhead Research Corp. (Nasdaq: ARWR) shares are down more than 5% after the biotech company announced Friday morning that interim Phase I data had been published on its anti-cancer drug IT-101. The data was published in the 2007 American Society for Clinical Oncology Proceedings. In the article, the authors wrote that “the stable disease rate, although not yet conclusive, is consistent with promising efficacy.”

These are the biggest percentage losers in Friday's trading among companies with market capitalizations under $500 million:

The Russell 2000 is losing ground along with the other major U.S. indices as investors anxiously await the Federal Reserve’s decision on interest rate policy.  Economists are expecting the U.S. central bank to keep rates steady at 5.25%.  The Fed will announce its decision at 2:15 p.m. ET.

Physicians Formula Holdings Inc.’s (Nasdaq: FACE) stock sank after the closing bell today after the Azusa, Calif.-based company released its first quarter financial results and second quarter outlook.

For the three months ended March 31, the cosmetics firm posted net income of $0.30 on revenue of $35.7 million. Net income included $0.03 per share of non-cash compensation expense after tax and $0.01 per share of secondary offering costs after tax.

Excluding these items, adjusted net income per diluted common share would have been $0.34 for the first quarter of 2007.

Three analysts polled by Thomson First Call had estimated earnings per share of $0.27 on revenue of $34 million.

Physicians Formula Holdings Inc.’s (Nasdaq: FACE) stock dropped by $1.90, or 8.7%, to $20.05 after the closing bell today after the Azusa, Calif.-based company released its first quarter financial results and second quarter outlook. For the three months ended March 31, the cosmetic company posted net income of $0.30 on revenue of $35.7 million. Net income included $0.03 per share of non-cash compensation expense after tax and $0.01 per share of secondary offering costs after tax. Excluding these items, adjusted net income per diluted common share would have been $0.34 for the first quarter of 2007. Three analysts polled by Thomson First Call had estimated earnings per share of $0.27 on revenue of $34 million. Looking ahead, though, the company predicted it would report a net loss between $0.04 and $0.01 on revenue of between $24.5 million to $25.5 million for the second quarter. Analysts were expecting earnings per share of $0.18 on revenue of $28.6 million.

Shares of S1 Corp. (Nasdaq: SONE) dipped by $0.17, or 2.5%, to $6.78 in after-hours trading today when the Atlanta-based financial software company released its first quarter financial results and full-year guidance. S1 earned $0.05 per share on revenue of $47.6 million. Analysts had estimated earnings per share of $0.05 on revenue of $48.2 million. For 2007, S1 expects GAAP earnings of between $0.25 and $0.28 per share on revenue in the range of $200 million to $206 million. Analysts were expecting non-GAAP EPS of $0.21 on revenue of $201.2 million.

Shares of EpiCept Corporation (Nasdaq: EPCT) are gaining on news this morning that the pharmaceutical company’s drug Azixa for the treatment of primary and secondary brain tumors was shown to be effective in clinical studies.  Shares have moved up $0.11, or 5.07%, to $2.28.